Management of hip fracture in COVID-19 infected patients

• Published in: World journal of orthopedics 2022-06, Vol.13 (6), p.544-554
• Main Authors: Qin, Hao-Cheng, He, Zhong, Luo, Zhi-Wen, Zhu, Yu-Lian
• Format: Article
• Language: English
• Subjects: Minireviews
• ISSN: 2218-5836; 2218-5836
• DOI: 10.5312/wjo.v13.i6.544

Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fractures show no sign of abating. Extensive studies have shown that patients with hip fracture and COVID-19 have a multifold increase in mortality compared to those uninfected and a more complex clinical condition. At present, no detailed research has systematically analyzed the relationship between these two conditions and proposed a comprehensive solution. This article aims to systematically review the impact of COVID-19 on hip fracture and provide practical suggestions. We found that hip fracture patients with COVID-19 have higher mortality rates and more complicated clinical outcomes. Indirectly, COVID-19 prevents hip fracture patients from receiving regular medical treatment. With regard to the problems we encounter, we provide clinical recommendations based on existing research evidence and a clinical flowchart for the management of hip fracture patients who are COVID-19 positive. Our study will help clinicians adequately prepare in advance when dealing with such patients and optimize treatment decisions.